Van Cutsem, E., Valderrama, A., Bang, Y., Fuchs, C. S., Shitara, K., Janjigian, Y. Y., . . . Alsina, M. (2021). Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma.
Citación estilo ChicagoVan Cutsem, E., et al. Quality of Life With First-line Pembrolizumab for PD-L1-positive Advanced Gastric/gastroesophageal Junction Adenocarcinoma. 2021.
Cita MLAVan Cutsem, E., et al. Quality of Life With First-line Pembrolizumab for PD-L1-positive Advanced Gastric/gastroesophageal Junction Adenocarcinoma. 2021.
Precaución: Estas citas no son 100% exactas.